SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-031687
Filing Date
2022-11-14
Accepted
2022-11-14 09:00:58
Documents
67
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1198401
2 form10-q_001.jpg GRAPHIC 7881
3 ex31-1.htm EX-31.1 19837
4 ex31-2.htm EX-31.2 19921
5 ex32-1.htm EX-32.1 7345
6 ex32-2.htm EX-32.2 7545
  Complete submission text file 0001493152-22-031687.txt   5996666

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE mrzm-20220930.xsd EX-101.SCH 47317
8 XBRL CALCULATION FILE mrzm-20220930_cal.xml EX-101.CAL 50270
9 XBRL DEFINITION FILE mrzm-20220930_def.xml EX-101.DEF 187758
10 XBRL LABEL FILE mrzm-20220930_lab.xml EX-101.LAB 394091
11 XBRL PRESENTATION FILE mrzm-20220930_pre.xml EX-101.PRE 298192
61 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 971895
Mailing Address 555 HERITAGE DRIVE SUITE 205 JUPITER FL 33458
Business Address 555 HERITAGE DRIVE SUITE 205 JUPITER FL 33458 561-935-9955
MARIZYME INC (Filer) CIK: 0001413754 (see all company filings)

IRS No.: 825464863 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-53223 | Film No.: 221380866
SIC: 2834 Pharmaceutical Preparations